Needle points

Big pharmaceutical companies are pressuring Congress to extend patents on
profitable drugs and save the firms from the horrors of having to compete
with generics. It's an especially blatant example of what almost everything
Congress does is really about: arranging things so that those with the best
lobbyists can make more money.